Topiramate Tablet
Product Images NDC 71610-486

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71610-486). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 25 mg (71610 0485 30)

FDA Label Image

Bottle Label 50 mg (71610 0486 30)

FDA Label Image

Bottle Label 100 mg (71610 0492 30)

FDA Label Image

Bottle Label 200 mg (71610 0493 15)

FDA Label Image

Aphena Pharma Solutions (TN)

FDA Label Image

Figure 1: Kaplan-meier Estimates Of Cumulative Rates For Time To First Seizure (Topiramate Fig1)

The given text seems to be a chart depicting "Cumulative Rates for Time to First Seizure" with two different dosages of "Topiramate". The dosages are "50 mg/day" and "400 mg/day". The chart shows measurements in percentage from 0 to 50. Other than that, there is no other information or context available to provide a more comprehensive description.*

FDA Label Image

Table 12: Efficacy Results In Double-blind, Placebo-controlled, Add-on Epilepsy Trials (Topiramate Fig2)

This appears to be a table or chart related to a study involving the drug Topiramate. The table shows the dosage of the drug given as well as the number of participants in each group. There are also some statistical values listed at the bottom. No further information or context is available in the given text.*

FDA Label Image

Chemical Structure (Topiramate Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.